Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	15.56	26.72	23.12
Graham Fair Price	-7.08	45.17	48.61
PEG	-25.47	-1.02	1.37
Price/Book	7.63	3.09	2.88
Price/Cash Flow	23.92	73.77	59.53
Prices/Earnings	26.99	14.96	11.78
Price/Sales	14.58	11.02	9.62
Price/FCF	23.92	73.77	59.53
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-4.88	0.31	0.33
Operating Margin	-8.54	0.29	0.31
ROA	-14.65	0.03	0.03
ROE	0.06	0.05	-15.24
ROIC	0.05	0.04	-17.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	< 0.005	-315.44
Dividends QOQ	0.06	-0.34	454.77
EBIT QOQ	0.07	-0.14	94.67
EPS QOQ	0.09	-0.15	70.38
FCF QOQ	-0.18	-0.13	27.13
Revenue QOQ	0.03	-0.06	77.94
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	12.67	13.58	7.26
Days Sales Outstanding (DSO)	33.45	35.47	6.05
Inventory Turnover	7.11	6.63	-6.77
Debt/Capitalization	0.28	0.27	-2.07
Quick Ratio	1.21	1.13	-6.13
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	41.49	41.87	0.93
Cash	5.56	5.15	-7.48
Capex	-2.43	-2.48	-1.99
Free Cash Flow	2.00	1.76	-12.34
Revenue	12.40	11.76	-5.20
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.43	1.35	-5.74
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.98	2.07	4.50
Naive Interpretation	Member

06 - Financial Health · Weak

Rating